Literature DB >> 15218156

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

Alejandro A Rabinstein1, Jonathan A Friedman, Stephen D Weigand, Robyn L McClelland, Jimmy R Fulgham, Edward M Manno, John L D Atkinson, Eelco F M Wijdicks.   

Abstract

BACKGROUND: Clinical and radiologic predictors of cerebral infarction occurrence and location after aneurysmal subarachnoid hemorrhage have been seldom studied.
METHODS: We evaluated all patients admitted to our hospital with aneurysmal subarachnoid hemorrhage between 1998 and 2000. Cerebral infarction was defined as a new hypodensity located in a vascular distribution on computed tomography (CT) scan.
RESULTS: Fifty-seven of 143 patients (40%) developed a cerebral infarction. On univariate analysis, occurrence of cerebral infarction was associated with a worse World Federation of Neurological Surgeons grade (P=0.01), use of ventriculostomy catheter (P=0.01), preoperative vasospasm (P=0.03), surgical clipping (P=0.02), symptomatic vasospasm (P<0.01), and vasospasm on transcranial Doppler ultrasonography (TCD) or repeat angiogram (P<0.01). On multivariable analysis, only presence of symptoms ascribed to vasospasm (P<0.01) and evidence of vasospasm on TCD or angiogram predicted cerebral infarction (P<0.01). TCD and angiogram agreed on the diagnosis of vasospasm in 73% of cases (95% CI, 63% to 81%), but the diagnostic accuracy of this combination of tests was suboptimal for the prediction of cerebral infarction occurrence (sensitivity, 0.72; specificity, 0.68; positive predictive value, 0.67; negative predictive value, 0.72). Location of the cerebral infarction on delayed CT was predicted by neurological symptoms in 74%, by aneurysm location in 77%, and by angiographic vasospasm in 67%.
CONCLUSIONS: Evidence of vasospasm on TCD and angiogram is predictive of cerebral infarction on CT scan but sensitivity and specificity are suboptimal. Cerebral infarction location cannot be predicted in one quarter to one third of patients by any of the studied clinical or radiological variables.

Entities:  

Mesh:

Year:  2004        PMID: 15218156     DOI: 10.1161/01.STR.0000133132.76983.8e

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  99 in total

Review 1.  Intracranial hemorrhage.

Authors:  Andrew M Naidech
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

2.  MR angiography in patients with subarachnoid hemorrhage: adequate to evaluate vasospasm-induced vascular narrowing?

Authors:  Elke Hattingen; Stella Blasel; Richard Dumesnil; Hartmut Vatter; Friedhelm E Zanella; Stefan Weidauer
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

3.  Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

Authors:  Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

4.  Subarachnoid haemorrhage in patients > or = 75 years: clinical course, treatment and outcome.

Authors:  D J Nieuwkamp; G J E Rinkel; R Silva; P Greebe; D A Schokking; J M Ferro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

5.  Intensive care unit management of aneurysmal subarachnoid hemorrhage.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

6.  Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhage.

Authors:  Michael Moussouttas; Torrey Boland; Lily Chang; Ameesh Patel; Jaime McCourt; Mitchell Maltenfort
Journal:  J Neurol       Date:  2012-06-24       Impact factor: 4.849

7.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Abutaher M Yahia; Jawad F Kirmani; Adnan I Qureshi; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

8.  Unravelling the causes of cerebral damage in subarachnoid haemorrhage: might biomarkers help?

Authors:  A A Rabinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

Review 9.  Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Nima Etminan; Mervyn D I Vergouwen; Don Ilodigwe; R Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-02       Impact factor: 6.200

10.  Role of gap junctions in early brain injury following subarachnoid hemorrhage.

Authors:  Robert Ayer; Wanqiu Chen; Takashi Sugawara; Hidenori Suzuki; John H Zhang
Journal:  Brain Res       Date:  2009-12-16       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.